Teva Stays One Step Ahead Of Plan B Generic Competition
This article was originally published in The Pink Sheet Daily
Executive Summary
Company likely will gain three more years exclusivity for the branded nonprescription emergency contraceptive with FDA's approval of a revised dosage of Plan B.